ReviewFrontiers in immunology2026
Innate immune signaling-driven myeloid remodeling in cancer: inflammatory amplification, immune suppression, and therapeutic targeting.
Wenyi Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.